Albion Financial Group’s AbbVie ABBV Stock Holding History

Albion Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.74M	Buy	18,850 +50	+0.3%	+$10.8K	0.27%	66
2026 Q1	$4.09M	Sell	18,800 -5,171	-22%	-$1.15M	0.26%	67
2025 Q4	$5.48M	Sell	23,971 -22,007	-48%	-$5.01M	0.34%	61
2025 Q3	$10.6M	Buy	45,978 +252	+0.6%	+$51.3K	0.64%	45
2025 Q2	$8.49M	Buy	45,726 +288	+0.6%	+$53.5K	0.55%	47
2025 Q1	$9.52M	Buy	45,438 +220	+0.5%	+$42.8K	0.67%	42
2024 Q4	$8.04M	Buy	45,218 +1,219	+3%	+$224K	0.55%	45
2024 Q3	$8.69M	Buy	43,999 +1,266	+3%	+$236K	0.6%	42
2024 Q2	$7.33M	Buy	42,733 +178	+0.4%	+$29.5K	0.55%	40
2024 Q1	$7.75M	Buy	42,555 +30,123	+242%	+$5.19M	0.6%	39
2023 Q4	$1.93M	Hold	12,432	–	–	0.16%	73
2023 Q3	$1.85M	Hold	12,432	–	–	0.17%	73
2023 Q2	$1.67M	Sell	12,432 -11	-0.1%	-$1.61K	0.15%	80
2023 Q1	$1.98M	Hold	12,443	–	–	0.18%	77
2022 Q4	$2.01M	Sell	12,443 -256	-2%	-$39.3K	0.19%	77
2022 Q3	$1.7M	Sell	12,699 -98	-0.8%	-$14.1K	0.18%	79
2022 Q2	$1.96M	Sell	12,797 -500	-4%	-$76.4K	0.19%	78
2022 Q1	$2.16M	Sell	13,297 -2,514	-16%	-$365K	0.18%	79
2021 Q4	$2.14M	Sell	15,811 -185	-1%	-$21.9K	0.17%	86
2021 Q3	$1.73M	Hold	15,996	–	–	0.15%	93
2021 Q2	$1.8M	Buy	+15,996	New	+$1.8M	0.16%	89
2020 Q4	$1.67M	Buy	15,616 +1,105	+8%	+$106K	0.16%	84
2020 Q3	$1.27M	Buy	14,511 +1,660	+13%	+$156K	0.14%	89
2020 Q2	$1.26M	Buy	12,851 +5,025	+64%	+$442K	0.15%	84
2020 Q1	$596K	Buy	7,826 +2,539	+48%	+$216K	0.09%	114
2019 Q4	$468K	Buy	5,287 +193	+4%	+$16K	0.06%	146
2019 Q3	$386K	Sell	5,094 -500	-9%	-$34.3K	0.05%	154
2019 Q2	$407K	Hold	5,594	–	–	0.05%	154
2019 Q1	$451K	Buy	5,594 +60	+1%	+$4.91K	0.06%	149
2018 Q4	$510K	Hold	5,534	–	–	0.08%	130
2018 Q3	$523K	Hold	5,534	–	–	0.07%	136
2018 Q2	$513K	Hold	5,534	–	–	0.07%	132
2018 Q1	$524K	Hold	5,534	–	–	0.08%	124
2017 Q4	$535K	Hold	5,534	–	–	0.08%	124
2017 Q3	$492K	Hold	5,534	–	–	0.08%	128
2017 Q2	$401K	Buy	5,534 +2,400	+77%	+$161K	0.07%	138
2017 Q1	$204K	Sell	3,134 -156	-5%	-$9.81K	0.03%	178
2016 Q4	$206K	Buy	3,290 +7	+0.2%	+$427	0.03%	169
2016 Q3	$207K	Buy	+3,283	New	+$213K	0.04%	171
2015 Q3	–	Sell	-5,309	Closed	-$357K	–	178
2015 Q2	$357K	Buy	5,309 +24	+0.5%	+$1.57K	0.06%	136
2015 Q1	$309K	Hold	5,285	–	–	0.05%	141
2014 Q4	$346K	Hold	5,285	–	–	0.06%	137
2014 Q3	$305K	Hold	5,285	–	–	0.05%	142
2014 Q2	$298K	Sell	5,285 -149	-3%	-$7.82K	0.05%	152
2014 Q1	$279K	Buy	5,434 +39	+0.7%	+$1.97K	0.05%	154
2013 Q4	$285K	Buy	5,395 +100	+2%	+$4.92K	0.05%	141
2013 Q3	$237K	Sell	5,295 -2,999	-36%	-$133K	0.05%	145
2013 Q2	$343K	Buy	+8,294	New	+$363K	0.08%	104

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Albion Financial Group's ABBV Position: Q2 2026 in Review

Albion Financial Group increased its AbbVie (ABBV) stake by 0.27% in Q2 2026, buying an estimated $10.8K and bringing the position to 18,850 shares worth $4.74M. The position accounts for 0.27% of the portfolio, ranked #66.

Albion Financial Group first reported a position in ABBV in Q2 2013 and has held it in 48 quarters since. The position peaked at $10.6M in Q3 2025. 4,194 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Albion Financial Group held 18,850 shares of AbbVie worth $4.74M as of Q2 2026.
Albion Financial Group bought 50 AbbVie shares in Q2 2026, an estimated $10.8K.
AbbVie made up 0.27% of Albion Financial Group's portfolio in Q2 2026, its #66 holding.
Albion Financial Group first reported a position in AbbVie in Q2 2013 and has held it in 48 quarters since.
Albion Financial Group's AbbVie position peaked at $10.6M in Q3 2025.
4,194 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Albion Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.